Show simple item record

dc.creatorTajeu, Gabriel S.
dc.creatorColvin, Calvin L.
dc.creatorHardy, Shakia T.
dc.creatorBress, Adam P.
dc.creatorGaye, Bamba
dc.creatorJaeger, Byron C.
dc.creatorOgedegbe, Gbenga
dc.creatorSakhuja, Swati
dc.creatorSims, Mario
dc.creatorShimbo, Daichi
dc.creatorO'Brien, Emily C.
dc.creatorSpruill, Tanya M.
dc.creatorMuntner, Paul
dc.date.accessioned2024-03-13T20:23:48Z
dc.date.available2024-03-13T20:23:48Z
dc.date.issued2022-08-05
dc.identifier.citationTajeu GS, Colvin CL, Hardy ST, Bress AP, Gaye B, Jaeger BC, et al. (2022) Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study. PLoS ONE 17(8): e0270675. https://doi.org/10.1371/journal.pone.0270675
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/20.500.12613/9852
dc.description.abstractBackground: Maintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication. Methods: The Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000–2004), 2 (2005–2008), and 3 (2009–2013). Persistent BP control was defined as systolic BP <140 mm Hg and diastolic BP <90 mm Hg at all three visits. CVD events were assessed from Visit 3 through December 31, 2016. Hazard ratios (HR) for the association of persistent BP control with CVD outcomes were adjusted for age, sex, systolic BP, smoking, diabetes, and total and high-density lipoprotein cholesterol at Visit 3. Results: At Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were <65 years of age, women, had family income ≥$25,000 at each visit, and visited a health professional in the year prior to each visit. The multivariable adjusted HR (95% confidence interval) comparing participants with versus without persistent BP control was 0.71 (0.46–1.10) for CVD, 0.68 (0.34–1.34) for coronary heart disease, 0.65 (0.27–1.52) for stroke, and 0.55 (0.33–0.90) for heart failure. Conclusion: Less than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure.
dc.format.extent15 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofFaculty/ Researcher Works
dc.relation.haspartPLoS ONE, Vol. 17
dc.relation.isreferencedbyPublic Library of Science (PLoS)
dc.rightsAttribution CC BY
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAntihypertensives
dc.subjectCardiovascular diseases
dc.subjectHeart failure
dc.subjectBlood pressure
dc.subjectMedical risk factors
dc.subjectCardiovascular disease risk
dc.subjectAfrican American people
dc.subjectHypertension
dc.titlePrevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study
dc.typeText
dc.type.genreJournal article
dc.description.departmentHealth Services Administration and Policy
dc.relation.doihttp://dx.doi.org/10.1371/journal.pone.0270675
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeTemple University. College of Public Health
dc.creator.orcidTajeu|0000-0002-9982-5250
dc.temple.creatorTajeu, Gabriel S.
refterms.dateFOA2024-03-13T20:23:48Z


Files in this item

Thumbnail
Name:
TajeuEtAl-JournalArticle-2022- ...
Size:
667.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY